カテゴリ： GlobalData, アメリカ, 企業調査

Ethicon US LLC：製品パイプライン分析

◆英語タイトル：Ethicon US LLC - Product Pipeline Analysis, 2017 Update
◆商品コード：DATA8010116
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月27日
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocars, hemostats, endocutters, suturing devices, endoscopic instruments, electrosurgical and irrigation products, meshes and allografts. Its products are used in minimally invasive and open surgical procedures to treat colorectal, thoracic, and women’s health conditions, hernias, cancer and obesity. Ethicon also offers ultrasonic energy devices and advanced bipolar energy devices. The company has medical education and surgical training, manufacturing, and sales facilities in the Americas, Europe and Asia-Pacific. Ethicon is headquartered in Cincinnati, Ohio, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ethicon US LLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Ethicon US LLC Company Overview 6
Ethicon US LLC Company Snapshot 6
Ethicon US LLC Pipeline Products and Ongoing Clinical Trials Overview 6
Ethicon US LLC – Pipeline Analysis Overview 9
Business Description 9
Ethicon US LLC – Key Facts 10
Ethicon US LLC – Major Products and Services 11
Ethicon US LLC Pipeline Products by Development Stage 15
Ethicon US LLC Ongoing Clinical Trials by Trial Status 17
Ethicon US LLC Pipeline Products Overview 19
Additional PLUS Barbed Suture 19
Additional PLUS Barbed Suture Product Overview 19
Circular Anal Dilator 20
Circular Anal Dilator Product Overview 20
EVICEL Lap Airless Spray Accessory 21
EVICEL Lap Airless Spray Accessory Product Overview 21
Flowable thrombin 22
Flowable thrombin Product Overview 22
Gynecare GynOcclude 23
Gynecare GynOcclude Product Overview 23
GYNECARE Next Generation Pelvic Floor Repair Device 24
GYNECARE Next Generation Pelvic Floor Repair Device Product Overview 24
GYNECARE PROLIFT Next Generation 25
GYNECARE PROLIFT Next Generation Product Overview 25
GYNECARE SUI Sling Next Generation 26
GYNECARE SUI Sling Next Generation Product Overview 26
Next Gen Automated Endoscope Reprocessor 27
Next Gen Automated Endoscope Reprocessor Product Overview 27
Next Gen Hemostat Kit 28
Next Gen Hemostat Kit Product Overview 28
PRINEO Next Generation 29
PRINEO Next Generation Product Overview 29
Robotic-assisted Surgical Device 30
Robotic-assisted Surgical Device Product Overview 30
SURGIFLO – Sterile Field Preparation 31
SURGIFLO – Sterile Field Preparation Product Overview 31
VICRYL (Polydactin 910) – Next Gen 32
VICRYL (Polydactin 910) – Next Gen Product Overview 32
VICRYL (Polydactin 910) – Next Gen Clinical Trial 33
Vicryl Rapide Plus Suture 34
Vicryl Rapide Plus Suture Product Overview 34
Vicryl Rapide Plus Suture Clinical Trial 35
Ethicon US LLC – Key Competitors 36
Ethicon US LLC – Key Employees 37
Ethicon US LLC – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Business Unit 39
Recent Developments 40
Ethicon US LLC, Recent Developments 40
Dec 13, 2017: Ethicon Transvaginal Mesh Lawsuit Goes to Trial in New Jersey, Bernstein Liebhard LLP Reports 40
Nov 10, 2017: Ethicon’s BIOPATCH Protective Disk with CHG Meets New CDC Recommendation and Continues as the Standard of Care to Reduce Intravascular Catheter-related Blood Stream Infections 40
Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes 41
Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products 41
Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017 42
Aug 31, 2017: Ethicon Highlights the Importance of Choice, at IFSO 2017 43
Aug 30, 2017: Ethicon Reports Major Progress On Multi-Year Initiative To Fill Clinical And Economic Evidence Gaps And Expand Access To Bariatric Surgery 43
Aug 07, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania, As Sixth Trial Kicks Off in Philadelphia, Bernstein Liebhard Reports 45
Jun 06, 2017: Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat 45
May 24, 2017: LINX more effective than Omeprazole at controlling regurgitation and improving quality of life in patients with Gastroesophageal Reflux Disease 46
Appendix 47
Methodology 47
About GlobalData 49
Contact Us 49
Disclaimer 50

List of Tables
Ethicon US LLC Pipeline Products and Ongoing Clinical Trials Overview 6
Ethicon US LLC Pipeline Products by Equipment Type 7
Ethicon US LLC Pipeline Products by Indication 8
Ethicon US LLC Ongoing Clinical Trials by Trial Status 8
Ethicon US LLC, Key Facts 10
Ethicon US LLC, Major Products and Services 11
Ethicon US LLC Number of Pipeline Products by Development Stage 15
Ethicon US LLC Pipeline Products Summary by Development Stage 16
Ethicon US LLC Ongoing Clinical Trials by Trial Status 17
Ethicon US LLC Ongoing Clinical Trials Summary 18
Additional PLUS Barbed Suture - Product Status 19
Additional PLUS Barbed Suture - Product Description 19
Circular Anal Dilator - Product Status 20
Circular Anal Dilator - Product Description 20
EVICEL Lap Airless Spray Accessory - Product Status 21
EVICEL Lap Airless Spray Accessory - Product Description 21
Flowable thrombin - Product Status 22
Flowable thrombin - Product Description 22
Gynecare GynOcclude - Product Status 23
Gynecare GynOcclude - Product Description 23
GYNECARE Next Generation Pelvic Floor Repair Device - Product Status 24
GYNECARE Next Generation Pelvic Floor Repair Device - Product Description 24
GYNECARE PROLIFT Next Generation - Product Status 25
GYNECARE PROLIFT Next Generation - Product Description 25
GYNECARE SUI Sling Next Generation - Product Status 26
GYNECARE SUI Sling Next Generation - Product Description 26
Next Gen Automated Endoscope Reprocessor - Product Status 27
Next Gen Automated Endoscope Reprocessor - Product Description 27
Next Gen Hemostat Kit - Product Status 28
Next Gen Hemostat Kit - Product Description 28
PRINEO Next Generation - Product Status 29
PRINEO Next Generation - Product Description 29
Robotic-assisted Surgical Device - Product Status 30
Robotic-assisted Surgical Device - Product Description 30
SURGIFLO - Sterile Field Preparation - Product Status 31
SURGIFLO - Sterile Field Preparation - Product Description 31
VICRYL (Polydactin 910) - Next Gen - Product Status 32
VICRYL (Polydactin 910) - Next Gen - Product Description 32
VICRYL (Polydactin 910) - Next Gen - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 33
VICRYL (Polydactin 910) - Next Gen - Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures 33
Vicryl Rapide Plus Suture - Product Status 34
Vicryl Rapide Plus Suture - Product Description 34
Vicryl Rapide Plus Suture - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study 35
Vicryl Rapide Plus Suture - Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures 35
Ethicon US LLC, Key Employees 37
Ethicon US LLC, Other Locations 38
Ethicon US LLC, Subsidiaries 38
Ethicon US LLC, Business Unit 39
Glossary 48

★海外企業調査レポート[Ethicon US LLC：製品パイプライン分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Dun & Bradstreet Corporation：企業の戦略・SWOT・財務分析
    The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report Summary The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Tivoli A/S：企業の戦略・SWOT・財務分析
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Subaru Corporation (7270)：企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Northwest Territories Power Corp：企業の戦略的SWOT分析
    Northwest Territories Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • PhaseBio Pharmaceuticals Inc：企業のM&A・事業提携・投資動向
    PhaseBio Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PhaseBio Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Enel Green Power SpA：電力：M&Aディール及び事業提携情報
    Summary Enel Green Power SpA (EGP) a subsidiary of Enel SpA, is an energy company that is involved in developing and operating renewable projects. It generates power from wind, biomass, geothermal, solar, and hydropower sources. The company also has interests in various power plants in under constru …
  • Titan Pharmaceuticals Inc (TTNP)-医療機器分野：企業M&A・提携分析
    Summary Titan Pharmaceuticals Inc (Titan) is a biopharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio offers prob …
  • Bank of Panhsin：企業の戦略・SWOT・財務情報
    Bank of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Galena Biopharma Inc (GALE)-医療機器分野：企業M&A・提携分析
    Summary Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company's pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding pro …
  • ICF International, Inc.：企業の戦略・SWOT・財務分析
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Audentes Therapeutics Inc (BOLD)：企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …
  • Kuraray Co Ltd (3405)：企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Geron Corp (GERN)-製薬・医療分野：企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • CGN New Energy Holdings Co Ltd (1811)：企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Informa plc：企業の戦略・SWOT・財務分析
    Informa plc - Strategy, SWOT and Corporate Finance Report Summary Informa plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Qantas Airways Ltd (QAN)：企業の財務・戦略的SWOT分析
    Qantas Airways Ltd (QAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Yes Bank Ltd：企業の戦略・SWOT・財務情報
    Yes Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Yes Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Assam Company India Ltd (ASSAMCO)：企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Teva Pharmaceutical Industries Ltd (TEVA)：企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Zhejiang Yatai Pharmaceutical Co Ltd (002370)：製薬・医療：M&Aディール及び事業提携情報
    Summary Zhejiang Yatai Pharmaceutical Co Ltd (Yatai Pharmaceutical), formerly Asia-Pacific Pharmaceutical Factory, is a pharmaceutical company. The company develops, researches, and manufactures pharmaceuticals including penicillin, cephalosporins and hormones. It offers transdermal controlled-relea …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆